Leiomyosarcoma: Personalized Sarcoma Therapy - Fritz C. Eilber, MD | UCLA Cancer Care

Explore the history and advancements in Leiomyosarcoma treatment at UCLA in this informative lecture by Dr. Fritz C. Eilber, Director of the UCLA Sarcoma Clinical/Translational Research Program. Delve into various sarcoma subtypes, survival rates, and prognostic models using data from Sloan Kettering. Gain insights into the importance of accurate diagnosis, preoperative planning, and the role of multidisciplinary teams in sarcoma treatment. Learn about cutting-edge research, including surgical orthotopic implantation and mouse model treatments. Discover the challenges of misdiagnosis, environmental factors, and the significance of fresh tissue samples. Understand the complexities of treating low-grade and high-grade sarcomas, and the potential of personalized therapy approaches in improving patient outcomes.

Intro
Sarcoma subtypes
Sloan Kettering data
Leiomyosarcoma prevalence
Survival
Grade
Size
Prognostic Model
Data Sets
nomagrams
sitespecific nomogram
data set
how it works
Surgery
Malignant Potential
Imaging
Retroperitoneal disease
Core biopsy
Examples
Importance of Diagnosis
Preoperative Planning
Vascular Graph
Multidisciplinary Team
Imaging review
Multidisciplinary sarcoma center
Clinical trials
How does the drug work
Surgical orthotopic implantation
Treatment of mouse models
Summary data
Lowgradesarcoma
Treatment of highgradesarcoma
Is it feasible
Misdiagnosis
Sarcoma error rate
Environmental factors
Fresh tissue
Laparoscopy